🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

EU regulators set to clear Dow, DuPont deal - sources

Published 22/02/2017, 17:00
© Reuters. The Dupont logo is displayed on a board above the floor of the New York Stock Exchange shortly after the opening bell in New York
DJI
-
DOW
-
BAYGN
-
SYENF
-
DD
-
MON
-
096770
-

By Foo Yun Chee

BRUSSELS (Reuters) - Dow Chemical (N:DOW) and DuPont (N:DD) are set to win EU antitrust approval for their $130 billion (104 billion pound) merger, two people familiar with the matter said on Wednesday, one of three mega deals in the agrochemicals industry.

The deal, which still needs approval from U.S. and other regulators, has faced intense scrutiny from the European Commission. Of particular concern is combining the two companies' agricultural businesses which sell seeds and crop protection chemicals, including insecticides and pesticides.

The EU competition enforcer had expressed concerns about whether the merged company would still be incentivised to produce new herbicides and pesticides in the future.

This month, DuPont offered to sell a portion of its crop protection business and related research and development, while Dow agreed to sell its acid copolymers and ionomers business to South Korea's SK Innovation (KS:096770) if the merger goes ahead.

The companies fine-tuned their concessions after the Commission received feedback from rivals and customers last week.

"These were very minor tweaks," one of the people said.

The Commission will not seek third parties' views on the changes, a clear sign that it will approve the deal, the source said.

The Commission, which is scheduled to rule on the merger by April 4, declined to comment. Dow and DuPont did not immediately respond to a request for comment.

Dow and DuPont shares added gains in New York after the Reuters story. Dow was trading 3.8 percent higher at $63.54 and DuPont was up 3.8 percent at $80.

The other two big deals pending in the sector are ChemChina's $43 billion bid for Swiss pesticides and seeds group Syngenta (S:SYNN), and German drugs and pesticides maker Bayer's (DE:BAYGn) $66 billion deal to take over U.S. seeds giant Monsanto (N:MON).

© Reuters. The Dupont logo is displayed on a board above the floor of the New York Stock Exchange shortly after the opening bell in New York

Sources have told Reuters that the European Commission is expected to give the green light to the ChemChina deal, the largest foreign acquisition by a Chinese company.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.